Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,078,323
  • Shares Outstanding, K 682,483
  • Annual Sales, $ 863,500 K
  • Annual Income, $ -188,860 K
  • EBIT $ -104 M
  • EBITDA $ 2 M
  • 60-Month Beta 1.65
  • Price/Sales 1.23
  • Price/Cash Flow N/A
  • Price/Book 0.78

Options Overview Details

View History
  • Implied Volatility 66.89% ( +8.18%)
  • Historical Volatility 39.76%
  • IV Percentile 35%
  • IV Rank 17.16%
  • IV High 339.52% on 12/27/23
  • IV Low 10.42% on 06/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 385
  • Volume Avg (30-Day) 1,817
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 481,555
  • Open Int (30-Day) 477,577

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.08
  • Number of Estimates 5
  • High Estimate -0.03
  • Low Estimate -0.15
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3700 +17.15%
on 11/07/24
1.7100 -6.14%
on 11/13/24
+0.1850 (+13.03%)
since 10/25/24
3-Month
1.3700 +17.15%
on 11/07/24
1.7450 -8.02%
on 09/17/24
-0.0050 (-0.31%)
since 08/23/24
52-Week
0.8516 +88.47%
on 01/05/24
1.7450 -8.02%
on 09/17/24
+0.0950 (+6.29%)
since 11/24/23

Most Recent Stories

More News
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference

OPK : 1.6300 (+3.16%)
Opko Health (OPK) Q3 2024 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2024.

OPK : 1.6300 (+3.16%)
OPKO Health: Q3 Earnings Snapshot

OPKO Health: Q3 Earnings Snapshot

OPK : 1.6300 (+3.16%)
OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results

OPK : 1.6300 (+3.16%)
OPKO Health to Report Third Quarter 2024 Financial Results on November 7, 2024

OPK : 1.6300 (+3.16%)
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program

OPK : 1.6300 (+3.16%)
Opko Health (OPK) Q2 2024 Earnings Call Transcript

OPK earnings call for the period ending June 30, 2024.

OPK : 1.6300 (+3.16%)
OPKO Health: Q2 Earnings Snapshot

OPKO Health: Q2 Earnings Snapshot

OPK : 1.6300 (+3.16%)
Opko Health (OPK) Q1 2024 Earnings Call Transcript

OPK earnings call for the period ending March 31, 2024.

OPK : 1.6300 (+3.16%)
OPKO Health: Q1 Earnings Snapshot

OPKO Health: Q1 Earnings Snapshot

OPK : 1.6300 (+3.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and...

See More

Key Turning Points

3rd Resistance Point 1.6700
2nd Resistance Point 1.6400
1st Resistance Point 1.6100
Last Price 1.6300
1st Support Level 1.5500
2nd Support Level 1.5200
3rd Support Level 1.4900

See More

52-Week High 1.7450
Last Price 1.6300
Fibonacci 61.8% 1.4037
Fibonacci 50% 1.2983
Fibonacci 38.2% 1.1929
52-Week Low 0.8516

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar